James C. Hyde - Feb 10, 2022 Form 4 Insider Report for BALCHEM CORP (BCPC)

Role
Sr. Vice President
Signature
/s/ James C. Hyde, by Attorney in Fact, Mark Stach
Stock symbol
BCPC
Transactions as of
Feb 10, 2022
Transactions value $
-$101,896
Form type
4
Date filed
2/14/2022, 08:04 AM
Next filing
Feb 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCPC Common Stock Award $0 +820 +5.81% $0.00 14.9K Feb 10, 2022 Direct F1
transaction BCPC Common Stock Award $0 +2.39K +16.04% $0.00 17.3K Feb 10, 2022 Direct F2
transaction BCPC Common Stock Tax liability -$102K -738 -4.26% $138.07* 16.6K Feb 10, 2022 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCPC Stock Option Award $0 +2.9K +7.35% $0.00 42.4K Feb 10, 2022 Common Stock 2.9K $138.07 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Ownership of the restricted stock does not vest in reporting person until three years from the grant date and is further subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Company and the reporting person.
F2 Acquired upon the settlement of performance shares granted on February 13, 2019, based upon a predetermined EBITDA performance target and total shareholder return against the Russell 2000 Index over a three-year period as a result of the satisfaction of those performance criteria.
F3 738 of the 2394 shares that vested February 10, 2022 were withheld to cover withholding taxes due upon vesting.
F4 Options vest 20% Year 1; 40% Year 2; and 40% Year 3.